---
title: "301047.SZ (301047.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301047.SZ/news.md"
symbol: "301047.SZ"
name: "301047.SZ"
parent: "https://longbridge.com/en/quote/301047.SZ.md"
datetime: "2026-05-21T07:44:22.208Z"
locales:
  - [en](https://longbridge.com/en/quote/301047.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301047.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301047.SZ/news.md)
---

# 301047.SZ (301047.SZ) — Related News

### [Sino Biological released its first-quarter performance, with a net profit attributable to the parent company of 32.1478 million yuan, an increase of 42.02%](https://longbridge.com/en/news/284420878.md)
*2026-04-28T16:07:04.000Z*
> Sino Biological released its Q1 2026 performance, with operating revenue of 183 million yuan, a year-on-year increase of

### [Sino Biological released its 2025 annual performance, with a net profit attributable to the parent company of 148 million yuan, an increase of 21.17%](https://longbridge.com/en/news/282539318.md)
*2026-04-13T11:57:03.000Z*
> Sino Biological released its 2025 annual report, with operating revenue of 700 million yuan, a year-on-year increase of 

### [03:22 ETThe 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard](https://longbridge.com/en/news/278508353.md)
*2026-03-10T07:25:36.000Z*
> Sino Biological has introduced ProPure™ endotoxin-free proteins, achieving levels below 0.05 EU/mg, significantly surpas

### [20:53 ETAdvancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains](https://longbridge.com/en/news/277707428.md)
*2026-03-04T01:55:36.000Z*
> Sino Biological has launched antigens for the 2026-2027 Northern Hemisphere influenza vaccine strains in response to WHO